Ribosomal protein L37a pseudogene 6 (RPL37AP6)

RPL37AP6 (ribosomal protein L37a pseudogene 6) is a processed pseudogene of the ribosomal protein L37a (RPL37A) gene in humans[7][2]. Pseudogenes are genomic DNA sequences similar to known genes but generally nonfunctional; they typically arise from duplication or retrotransposition events. RPL37AP6 does not encode a functional protein, and there is no evidence that it acts as a traditional therapeutic target such as a receptor, enzyme, or transporter. Like other pseudogenes, it may have a role in gene regulation at the RNA level, such as acting as a decoy for microRNAs or producing regulatory RNAs, but there are no functional or clinical data specifically for RPL37AP6[6]. It is not considered a therapeutic or druggable target, nor does it have established biomarker or disease associations. Key assessment: This entity is a pseudogene, not a protein or receptor. It is not regarded as a therapeutic target. Canonical name should be "Ribosomal protein L37a pseudogene 6" (RPL37AP6). Aliases exist but do not reflect a functional protein product. No interacting drugs, mechanisms of action, biomarkers, or safety concerns are relevant. Its major molecular classification is "pseudogene", not receptor, enzyme, etc. Its biological and disease roles are at most theoretical as per general pseudogene literature[6].

Other names

RPL37A_3_833RPL37AP6ribosomal protein L37a pseudogene 6